Title : Use of differentiated cholinergic and second messenger endpoints to evaluate cholinesterase inhibitors - Blusztajn_1995_Clin.Exp.Pharmacol.Physiol_22_368 |
Author(s) : Blusztajn JK , Davis RO |
Ref : Clinical & Experimental Pharmacology & Physiology , 22 :368 , 1995 |
Abstract : Blusztajn_1995_Clin.Exp.Pharmacol.Physiol_22_368 |
ESTHER : Blusztajn_1995_Clin.Exp.Pharmacol.Physiol_22_368 |
PubMedSearch : Blusztajn_1995_Clin.Exp.Pharmacol.Physiol_22_368 |
PubMedID: 7554433 |
Blusztajn JK, Davis RO (1995)
Use of differentiated cholinergic and second messenger endpoints to evaluate cholinesterase inhibitors
Clinical & Experimental Pharmacology & Physiology
22 :368
Blusztajn JK, Davis RO (1995)
Clinical & Experimental Pharmacology & Physiology
22 :368